AI-Designed Viruses Reach a Human Patient
AI-designed bacteriophages have been administered to a patient for the first time, but the company hasn’t disclosed the outcome. Here’s what the early lab results show—and what remains unknown.
AI-designed bacteriophages have been administered to a patient for the first time, but the company hasn’t disclosed the outcome. Here’s what the early lab results show—and what remains unknown.
AI-designed bacteriophages have been administered to a patient for the first time, but the company hasn’t disclosed the outcome. Here’s what the early lab results show—and what remains unknown.
Stanford bioengineers have created synthetic phages that are more effective than natural ones in killing E. coli, promising a new approach to combat bacterial infections.